Methylation status of MGMT gene promoter in meningiomas

Cancer Genetics and Cytogenetics

Volumn 187, Issue 1, 2008, Pages 25-27

  de Robles, Paula ^a,b   McIntyre, John ^a,b,c   Kalra, Sanjog ^a   Roldán, Gloria ^b,c   Cairncross, Gregory ^a,b   Forsyth, Peter ^b,c   Magliocco, Tony ^a,b   Hamilton, Mark ^a,b   Easaw, Jacob ^b,c  

^a UNIVERSITY OF CALGARY   (Canada)

^b Clark Smith Integrated Brain Tumor Research Centre   (Canada)

^c TOM BAKER CANCER CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

TEMOZOLOMIDE;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER RECURRENCE; CLINICAL ARTICLE; DNA METHYLATION; FEMALE; GENE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; MENINGIOMA; MGMT GENE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; TREATMENT OUTCOME;

ADULT; AGED; ANTINEOPLASTIC AGENTS, ALKYLATING; DACARBAZINE; DNA METHYLATION; DNA MODIFICATION METHYLASES; DNA REPAIR ENZYMES; DNA, NEOPLASM; FEMALE; HUMANS; MALE; MENINGEAL NEOPLASMS; MENINGIOMA; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; POLYMERASE CHAIN REACTION; PROMOTER REGIONS, GENETIC; TUMOR SUPPRESSOR PROTEINS;

EID: 55049086363     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cancergencyto.2008.07.006     Document Type: Article

References (16)

1. Asthagiri A., Helm G., and Sheehan J. Current concepts in management of Meningiomas and Shwanomas. Neurol Clin 25 (2007) 1209-1230
2. Lusis E., and Gutmann D.H. Meningioma: an update. Curr Opin Neurol 17 6 (2004) 687-692
3. Antinheimo J., Sankila R., Carpen O., Pukkala E., Sainio M., and Jaaskelainen J. Population-based analysis of sporadic and type 2 neurofibromatosis-associated meningiomas and schwannomas. Neurology 54 1 (2000) 71-76
4. Louis D., Ohgaki H., Wiestler O., Cavenee W., Burger P., Jouvet A., Scheithauer B., and Kleihues P. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 114 (2007) 97-109
5. Perry A., Stafford S.L., Scheithauer B.W., Suman V.J., and Lohse C.M. Meningioma grading: an analysis of histologic parameters. Am J Surg Pathol 21 12 (1997) 1455-1465
6. Chamberlain M.C. Meningiomas. Curr Treat Options Neurol 3 1 (2001) 67-76
7. Mirimanoff R.O., Dosoretz D.E., Linggood R.M., Ojemann R.G., and Martuza R.L. Meningioma: analysis of recurrence and progression following neurosurgical resection. J Neurosurg 62 1 (1985) 18-24
8. Wilson C.B. Meningiomas: genetics, malignancy, and the role of radiation in induction and treatment. The Richard C. Schneider Lecture. J Neurosurg 81 5 (1994) 666-675
9. Goldsmith B.J., Wara W.M., Wilson C.B., and Larson D.A. Postoperative irradiation for subtotally resected meningiomas. A retrospective analysis of 140 patients treated from 1967 to 1990. J Neurosurg 80 2 (1994) 195-201
10. Kondziolka D., Lunsford L.D., Coffey R.J., and Flickinger J.C. Stereotactic radiosurgery of meningiomas. J Neurosurg 74 4 (1991) 552-559
11. Kyritisis A.P. Chemotherapy for meningiomas. J neurooncol 29 (1996) 269-272
12. Chamberlain M.C., Tsao-Wei D., and Groshen S. Temozolomide for treatment-resistant recurrent meningioma. Neurology 62 (2004) 1210-1212
13. Stupp R., Warren M., van den Bent M., Weller M., Fisher B., Taphoorn M., Belanger K., Brandes A., Marosi C., Bogdahn U., Curschmann J., Janzer R., Ludwin S., Gorlia T., Allgeier A., Lacombe D., Cairncross G., Eisenhauer E., and Mirimanoff R. for the European Organization for research and treatment of cancer brain tumor and radiotherapy groups and the National Cancer Institue of Canada Clinical Trials Group. Radiotherapy plus concomitant and adjuvant Temozolomide for Glioblastoma. N Engl J Med 352 (2005) 987-996
14. Hegi M.E., Diserens A.C., Gorlia T., et al. MGMT gene silencing and benefit from temozolomide in glioblastoma. N Engl J Med 352 10 (2005) 997-1003
15. Möllemann M., Wolter M., Felsberg J., Collins P., and Reifenberger G. Frequent promoter hypermethylation and low expression of the MGMT gene in oligodendroglial tumors. Int J. Cancer 113 (2005) 379-385
16. Bello M.J., Aminoso C., Lopez-Marin I., Arjona D., Gonzalez-Gomez P., Alonso M.E., Lomas J., de Campos J., Kusak M.E., Vaquero J., Isla A., Gutierrez M., Sarasa J., and Rey J. DNA methylation of multiple promoter-associated CpG islands in meningiomas: relationship with the allelic status at 1p and 22q. Acta Neuropathol 108 (2004) 413-421